精品国产一区二区桃色

Journal News

From the journals: 精品国产一区二区桃色

Latavia Hill
April 23, 2020

A risk factor for autoimmune thyroid diseases, phenotypic adaptation in the agent that causes burn infections and a new insight on a cell cycle protein. We offer summaries of papers on these topics recently published in the journal Molecular & Cellular Proteomics.

Identification of another risk factor for AITDs

Autoimmune thyroid diseases, or AITDs, are caused by a self-mediated attack on thyroid cells and ultimately affect thyroid gland function. Two common AITDs are Hashmito’s thyroiditis, or HT, and Graves’ disease. Before clinical symptoms appear, the human body produces autoantibodies against the thyroid cells, which allows clinicians to detect these illnesses. Researchers hypothesize that thyroid peroxidase antibody, or TPOab, a commonly used diagnostic marker, has a role in autoimmunity by modulating IgG glycosylation.

Recently, Tiphaine C. Martin of King’s College and an international team published in the journal Molecular & Cellular Proteomics that focused on determining whether immunoglobulin G, or IgG, glycosylation is associated with TPOAb that is positive for AITD and whether AITD and glycan structures share any genetic, heritable factors.

In this study, the researchers found that TPOAb level and AITD are associated with decreased IgG core fucosylation. Additionally, they showed that HT is linked to a decrease of antennary alpha1,2 fucose and that enrichment of IgG N-glycan traits is associated with genes FUT8 and IKZF1, which are essential for IgG core fucose formation. The researchers could not determine genetic variances between AITD and IgG N-glycan traits; however, they showed that decreased core fucosylation and antennary alpha1,2 fucose are not associated with gene expression alteration in peripheral blood mononuclear cells.

In conclusion, the researchers propose a model in which FUT8 and IKZF1 have an aberrant expression in a tissue-specific manner instead of in the blood. They think this model will show that the altered expression causes antibody-dependent cell-mediated cytotoxicity directed against the thyrocyte due to afucosylated TPOAb antibodies. In turn, they propose that this cytoxicity leads to AITD development.

mcp-FTJ-glycosylation-TPOAb0-706x408.jpg
Tiphaine Martin et al./精品国产一区二区桃色
This proposed model illustrates the role of FUT8 and IKZF1 in the development of autoimmune thyroid diseases.

How a pathogen adapts to survive

Pseudomonas aeruginosa, a Gram-negative opportunistic pathogen, causes burn wound infections and pneumonia. It produces siderophores to acquire iron for survival and can express various iron-uptake pathways with specific TonB-dependent transporters, or TBDTs, which allows itto use exosiderophores produced by other bacterial species.

Quentin Perraud of the University of Strasbourg and a team of researchers in France recently published in the journal Molecular & Cellular Proteomics focused on understanding how P. aeruginosa selects, regulates and adapts its expression levels of iron-uptake pathways in response to environmental stimuli. In this study, the researchers showed that P. aeruginosa uses different siderophores at different chelating efficiencies, with catechol siderophores being the most powerful. They also showed that expression of the TBDTs varied when P. aeruginosa was grown in three different media, which suggests that different phenotypic patterns exist. This work also shows that P. aeruginosa can detect the presence of epithelial cells and adjust gene expression accordingly. These findings show that P. aeruginosasenses changes in its environment and alters the expression of its various iron pathways to acquire iron and effectively compete with other bacterial species.

An essential protein in the cell cycle

Each day, millions of cells undergo cell division to make daughter cells. This extensively studied cell cycle consists of four phases: a gap phase, synthesis, a second gap and mitosis. Each checkpoint in this cycle is crucial, because any irregularities can lead to uncontrollable cell growth, also known as cancer.
by Patrick Herr of Karolinska Insitutet and a team in Sweden, published in the journal Molecular & Cellular Proteomics, focused on dissecting cell cycle dynamics at the protein level in asynchronous cells, using methods other than chemical synchronization. The researchers characterized protein oscillation patterns over the course of the cell cycle and found that many vital processes are affected. The team detected differences in mRNA abundance and phosphorylation patterns among cell cycle phase groups. They characterized predicted cell cycle–dependent proteins, including S-adenosylmethionine synthase, or MAT2A. They found that MAT2A nuclear localization was enriched in synthesis and in the second gap and mitosis, and they speculate that this protein is essential for epigenetic histone methylation during DNA replication.

Enjoy reading ASBMB Today?

Become a member to receive the print edition four times a year and the digital edition monthly.

Learn more
Latavia Hill

Latavia Hill is a graduate student studying microbiology at the University of Kansas.

Get the latest from ASBMB Today

Enter your email address, and we鈥檒l send you a weekly email with recent articles, interviews and more.

Latest in Science

Science highlights or most popular articles

RA patient blood reveals joint innerworkings
Journal News

RA patient blood reveals joint innerworkings

July 25, 2025

Researchers in the Netherlands use mass spectrometry to compare the proteome of plasma and synovial fluid in rheumatoid arthritis patients and find a correlation. Read more about this recent paper in Molecular & Cellular Proteomics.

Hope for a cure hangs on research
Essay

Hope for a cure hangs on research

July 17, 2025

Amid drastic proposed cuts to biomedical research, rare disease families like Hailey Adkisson鈥檚 fight for survival and hope. Without funding, science can鈥檛 鈥渃atch up鈥 to help the patients who need it most.

Before we鈥檝e lost what we can鈥檛 rebuild: Hope for prion disease
Feature

Before we鈥檝e lost what we can鈥檛 rebuild: Hope for prion disease

July 15, 2025

Sonia Vallabh and Eric Minikel, a husband-and-wife team racing to cure prion disease, helped develop ION717, an antisense oligonucleotide treatment now in clinical trials. Their mission is personal 鈥 and just getting started.

Defeating deletions and duplications
News

Defeating deletions and duplications

July 11, 2025

Promising therapeutics for chromosome 15 rare neurodevelopmental disorders, including Angelman syndrome, Dup15q syndrome and Prader鈥揥illi syndrome.

Using 'nature鈥檚 mistakes' as a window into Lafora disease
Feature

Using 'nature鈥檚 mistakes' as a window into Lafora disease

July 10, 2025

After years of heartbreak, Lafora disease families are fueling glycogen storage research breakthroughs, helping develop therapies that may treat not only Lafora but other related neurological disorders.

Cracking cancer鈥檚 code through functional connections
News

Cracking cancer鈥檚 code through functional connections

July 2, 2025

A machine learning鈥揹erived protein cofunction network is transforming how scientists understand and uncover relationships between proteins in cancer.